Clinical Trial Update: Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating safety, tolerability, pharmacodynamics, and pharmacokinetics of inhaled AZD8871 in asthmatic and COPD subjects; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD8871 (AZD8871)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma (Part 1), COPD (Part 2) | Phase 1 | Status: COMPLETED | Results posted: 2018-11-08